The quality of bone tissue and its mineral density in patients with chronic obstructive pulmonary disease

Authors

  • V. Povoroznyuk State Institution “D. F. Chebotarev Institute of Gerontology by the NAMS of Ukraine”, Kyiv, Ukraine http://orcid.org/0000-0002-9770-4113
  • N.P. Masik National Pirоgov Memorial Medical University, Vinnytsa, Ukraine
  • N. Dzerovych State Institution “D. F. Chebotarev Institute of Gerontology by the NAMS of Ukraine”, Kyiv, Ukraine http://orcid.org/0000-0002-4278-972X

DOI:

https://doi.org/10.22141/2224-1507.10.3.2020.212036

Keywords:

chronic obstructive pulmonary disease, trabecular bone score, bone mineral density

Abstract

Background. The objective of the work is to study the effect of chronic obstructive pulmonary disease (COPD) on mi­neral density (BMD) and trabecular bone score (TBS), depen­ding on the degree of severity and women's age. Materials and me­thods. We have examined 30 women aged 57.43 ± 7.87 years, patients with COPD of various stages (GOLD 1–4). We have studied the BMD Total, BMD the lumbar spine (L1–L4), BMD Femur, and BMD Radius by means of dual-energy X-ray absorptiometry (DEXA). TBS of the lumbar spine (L1–L4) was determined by the TBS iNsight method (Med-Imaps, Pessac, France). Results. A significant decrease of the BMD was found at every skeletal area star­ting from GOLD 3, whereas at the L1–L4 level the BMD began to decrease at GOLD 2. The correlation was found between the severity of COPD and BMD Femur (r = –0.75, p < 0.05), BMD Radius (r = –0 73, p < 0.05), BMD L1–L4 (r = –0.80, p < 0.05) BMD Total (r = –0.73, p < 0.05). Starting from GOLD 2, the values of TBS significantly decreased and corresponded to the partial bone quality loss. The most pronounced changes occurred at the level of TBS L1 and corresponded to a significant bone quality loss already at GOLD 2. The TBS progressively decreased and at GOLD 3–4 corresponded to a significant loss of bone quality. The correlation was found between the severity of COPD and TBS of the spine at the level of L1–L4 (r = –0.76, p<0.05), TBS of the spine at the le­vel of L2–L4 (r = –0.75, p<0.05). Conclusions. Age equally affects both BMD and TBS in women with COPD, and from the age of 45, these rates progressively decrease. The effect of COPD on bone tissue according to the severity of the disease is heterogeneous at different segments of the axial skeleton. The earliest changes concern the decrease in BMD L1-L4 (1.19 ± 0.05) g/cm2 compared to GOLD 1 (1.39 ± 0.05) g/cm2 (p < 0.05) and TBS L1 (1.17 ± 0.06) in comparison with GOLD 1 (1.34 ± 0.06; p < 0.05), whose decrease is observed already at GOLD 2.

References

Mostovoy YM, Slepchenko NS, Dmytriiev KD, Sidorov AA. Chronic obstructive pulmonary disease and the heart: achievments and current questions. Ukr Pulmonol J. 2018;(4):56-61. https://doi.org/10.31215/2306-4927-2018-102-4-56-61. (in Ukrainian).

Pertseva ТО, Кonopkina LІ. Modern views on the diagnosis and treatment of chronic obstructive pulmonary disease. Ukr Pulmonol J. 2018;(4):13-15. (in Ukrainian).

Feshchenko YI. Urgent challenges of modern pulmonology. Ukr Pulmonol J. 2018;(4):8-12. (in Ukrainian).

Feshchenko YI, Gavrysyuk VK, Dziublyk AY, et al. Adapted clinical guideline: chronic obstructive pulmonary disease (part 1). Ukr Pulmonol J. 2019;(2):5-18. https://doi.org/10.31215/2306-4927-2019-104-2-5-18. (in Ukrainian).

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2007 Report. Fontana, WI: GOLD; 2007.

Masik NP. Vitamin D metabolism disturbances: one more extrapulmonary effect of systemic inflammation in chronic obstructive pulmonary disease. Ukr Pulmonol J. 2015;(3):39-43. (in Ukrainian).

Barabanova EN. GOLD 2017: what change were made in global strategy of treatment of chronic obstructive pulmonary disease and why? Pulmonologiya. 2017;27(2):274-282. https://doi.org/10.18093/0869-0189-2017-27-2-274-282. (in Russian).

Müllerova H, Maselli DJ, Locantore N, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999-1007. https://doi.org/10.1378/chest.14-0655.

Todoriko LD. Formation of systemic manifestations and definition of progression predictors of chronic obstructive pulmonary disease using a factor analysis. Ukr Pulmonol J. 2019;(1):49-54. https://doi.org/10.31215/2306-4927-2019-103-1-49-54. (in Ukrainian).

Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574-580. https://doi.org/10.1136/thx.2003.019588.

Ovsyannikov ES, Avdeev SN, Budnevsky AV. Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity. Therapeutic Archive. 2020;92(3):13-18. https://doi.org/10.26442/00403660.2020.03.000265. (in Russian).

Jaramillo JD, Wilson C, Stinson DS, et al. Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc. 2015;12(5):648-656. https://doi.org/10.1513/annalsats.201412-591oc.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2017 Report. Fontana, WI: GOLD; 2017. 139 p.

Gerych PR. Clinic-functional features of motion of cardio-respiratory pathology for patients with the chronic obstructive pulmonary disease. Bulletin of problems biology and medicine. 2017;1(139):121-127. (in Ukrainian).

Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165-1185. https://doi.org/10.1183/09031936.00128008.

Povoroznyk VV, Musiienko AS, Dzerovych NI. Trabecular bone score and bone mineral density in men with vertebral fractures. Bolʹ, sustavy, pozvonočnik. 2015;(17):38-42. https://doi.org/10.22141/2224-1507.1.17.2015.79019. (in Ukrainian).

Povoroznyuk VV, Dzerovych NI, Orlyk TV. Trabecular bone score in clinical practice: literature review and results of the own study. Problems of osteology. 2014;17(2):3-13. (in Ukrainian).

Povoroznyuk VV, Hans D, Dzerovych NI. Trabecular bone score in clinical practice. Bolʹ, sustavy, pozvonočnik. 2014;(16):14-22. https://doi.org/10.22141/2224-1507.4.16.2014.79638. (in Ukrainian).

Povoroznyuk VV, Dzerovych NI, Hans D. Trabecular bone score in clinical practice (review). Orthopaedics, traumatology and prosthetics. 2015;(2):126-136. https://doi.org/10.15674/0030-598720152126-136. (in Ukrainian).

Malanchuk VO, Kopchak OV. Evaluation of the quality of facial bones and skull classification of its type on the basis of biomechanical parameters. Ukrainian Medical Journal. 2013;(93):126-131. (in Ukrainian).

Brusko AT. The biological law of compliance of quantity and function of bone tissue. Visnyk ortopedii, travmatologii ta protezuvannja. 2010;(1):76-78. (in Ukrainian).

Orlyk TV, Povoroznyuk VV, Dzerovych NI. The role of quality trabecular bone in the formation of vertebral pain in postmenopausal women. Problems of osteology. 2015;18(1):51-54. (in Ukrainian).

Ministry of Нealth of Ukraine. Order on June 27, 2013 № 555. On Adoption and Implementation of Medical and Technological Documents on the Standardization of Medical Care for Chronic Obstructive Pulmonary Disease. Available from: https://zakon.rada.gov.ua/rada/show/v0555282-13#Text. Accessed: June 27, 2013. (in Ukrainian).

Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image [published correction appears in J Bone Miner Res. 2017 Nov;32(11):2319]. J Bone Miner Res. 2014;29(3):518-530. https://doi.org/10.1002/jbmr.2176.

Harvey NC, Glüer CC, Binkley N, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015;78:216-224. https://doi.org/10.1016/j.bone.2015.05.016.

Shevroja E, Lamy O, Kohlmeier L, Koromani F, Rivadeneira F, Hans D. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice. J Clin Densitom. 2017;20(3):334-345. https://doi.org/10.1016/j.jocd.2017.06.019.

Labotskii VV. Upravlenie znaniiami: tekhnologii, metody i sredstva predstavleniia, izvlecheniia i izmereniia znanii: uchebnoe posobie [Knowledge management: technologies, methods and means of representation, extraction and measurement of knowledge: a tutorial]. Minsk: Sovremennaia shkola; 2006. 387 p. (in Russian).

Casado E, Del Rio L, Gallego M, Arévalo M, Larrosa M. Trabecular bone score is severely affected in male patients with chronic obstructive pulmonary disease. Annals of the Rheumatic Diseases. 2016;75 (Suppl 2):1170. http://dx.doi.org/10.1136/annrheumdis-2016-eular.4752.

González J, Rodríguez-Fraile M, Rivera P, et al. Trabecular bone score in active or former smokers with and without COPD. PLoS One. 2019;14(2):e0209777. https://doi.org/10.1371/journal.pone.0209777.

Kim CW. Is Trabecular Bone Score a More Sensitive Marker for Osteoporosis in Asthmatics? Allergy Asthma Immunol Res. 2019;11(3):302-305. https://doi.org/10.4168/aair.2019.11.3.302.

Choi YJ, Lee HY, Yoon D, et al. Trabecular Bone Score Is More Sensitive to Asthma Severity and Glucocorticoid Treatment Than Bone Mineral Density in Asthmatics. Allergy Asthma Immunol Res. 2019;11(3):343-356. https://doi.org/10.4168/aair.2019.11.3.343.

Watanabe R, Tai N, Hirano J, Ban Y, Inoue D, Okazaki R. Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease. Osteoporos Int. 2018;29(3):615-623. https://doi.org/10.1007/s00198-017-4314-7.

Shevroja E, Lamy O, Kohlmeier L, Koromani F, Rivadeneira F, Hans D. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice. J Clin Densitom. 2017;20(3):334-345. https://doi.org/10.1016/j.jocd.2017.06.019.

Downloads

Published

2020-08-01

Issue

Section

Original Researches